Europe is scrambling to reconfigure its pharmaceutical supply chain for the Covid vaccine, report Chemical and Engineering News. 

When the COVID-19 pandemic exposed weaknesses in the pharmaceutical supply chain in the US—in particular its dependence on products outsourced to Asia—the government responded forcefully.